Literature DB >> 16352346

Major depressive disorder in adolescents: family psychiatric history predicts severe behavioral disinhibition.

Cheryl A King1, Michele S Knox, Nathan Henninger, Tuan Anh Nguyen, Neera Ghaziuddin, Azmaira Maker, Gregory L Hanna.   

Abstract

BACKGROUND: Major Depressive Disorder (MDD) becomes increasingly prevalent during adolescence and is associated with substantial psychiatric comorbidity and psychosocial impairment. The marked behavioral heterogeneity evident among adolescents with MDD suggests the possibility of distinct subtypes. This study was designed to determine whether family psychiatric histories differ between groups of MDD adolescents defined by the presence or absence of severe behavioral disinhibition.
METHODS: Adolescents with MDD (n = 71) completed the Buss-Durkee Hostility Inventory--Adapted, Adolescent Aggressive Incidents Interview (AAII), Measure of Aggression, Violence, and Rage in Children, Diagnostic Interview Schedule for Children, Suicidal Ideation Questionnaire-JR., Suicidal Behavior Inventory, and Reynolds Adolescent Depression Scale. Parents completed the Family Informant Schedule and Criteria, Children's Affective Liability Scale, AAII, and a partial DISC. Behavioral disinhibition (BD) measures were used to assign adolescents to MDD+BD (n = 41) and MDD-BD (n = 30) groups.
RESULTS: The MDD+BD group had a higher prevalence of drug use disorders in biological fathers than the MDD-BD group. The MDD+BD group also had higher proportions of paternal second degree relatives with alcohol use disorders, drug use disorders, and psychiatric hospitalizations, and a higher proportion of maternal second degree relatives with antisocial personality disorder. LIMITATIONS: Limitations include reliance on single informants for family psychiatric histories and the failure to distinguish between child- and adolescent-onset depression.
CONCLUSIONS: Family psychiatric histories differentiated MDD adolescents grouped by the presence or absence of behavioral disinhibition, suggesting possible etiologic mechanisms. Further research on subtypes or comorbid presentations may assist in the development of targeted treatment strategies.

Entities:  

Mesh:

Year:  2005        PMID: 16352346     DOI: 10.1016/j.jad.2005.09.011

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Adolescent nonsuicidal self-injury: the effects of personality traits, family relationships and maltreatment on the presence and severity of behaviours.

Authors:  Rossella Di Pierro; Irene Sarno; Sara Perego; Marcello Gallucci; Fabio Madeddu
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-22       Impact factor: 4.785

2.  Prediction of restraints among youth in a psychiatric hospital: application of translational action research.

Authors:  Carolyn J Tompsett; Sarah Domoff; Paul Boxer
Journal:  J Clin Psychol       Date:  2011-01-19

3.  Covariation of self- and other-directed aggression among inpatient youth: continuity in the transition to treatment and shared risk factors.

Authors:  Paul Boxer
Journal:  Aggress Behav       Date:  2010 May-Jun       Impact factor: 2.917

4.  National comorbidity survey replication adolescent supplement (NCS-A): I. Background and measures.

Authors:  Kathleen R Merikangas; Shelli Avenevoli; E Jane Costello; Doreen Koretz; Ronald C Kessler
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-04       Impact factor: 8.829

5.  Prevalence and predictors of affective lability after paediatric traumatic brain injury.

Authors:  Roma A Vasa; Stacy J Suskauer; Julia M Thorn; Luther Kalb; Marco A Grados; Beth S Slomine; Cynthia F Salorio; Joan P Gerring
Journal:  Brain Inj       Date:  2015-05-07       Impact factor: 2.311

6.  Is early-onset in major depression a predictor of specific clinical features with more impaired social function?

Authors:  Yan-Hong Liu; Lin Chen; Yun-Ai Su; Yi-Ru Fang; Manit Srisurapanont; Jin Pyo Hong; Ahmad Hatim; Hong Choon Chua; Dianne Bautista; Tian-Mei Si
Journal:  Chin Med J (Engl)       Date:  2015-03-20       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.